Hematology Oncology of Indiana and American Oncology Network Welcome Dr. Amy Braden
MWN-AI** Summary
Hematology Oncology of Indiana (HOI) and the American Oncology Network (AON) are excited to welcome Dr. Amy Braden, DO, to their team. With over a decade of experience as a Board-certified medical oncologist and hematologist, Dr. Braden brings a wealth of knowledge and expertise to the practice, where she is now accepting new patients. She received her Doctorate of Osteopathic Medicine from Nova Southeastern University and completed her residency in internal medicine at the Medical College of Wisconsin, followed by a hematology and oncology fellowship at the University of Wisconsin.
Dr. Braden expressed her enthusiasm for joining HOI, emphasizing the practice's strong reputation for providing high-quality, patient-centered cancer care. Brian P. Mulherin, MD, another oncologist at HOI, praised Dr. Braden’s background and dedication and believes her addition will greatly benefit both patients and staff alike.
HOI operates six locations in Indiana, including two in Indianapolis, and offers an extensive range of oncology services, such as specialty infusion services, pathology, pharmacy, clinical trials, and BiTE therapy. The practice focuses on comprehensive cancer treatment, underpinned by thorough research and an individualized approach to patient care.
Dr. Braden will serve patients at various HOI locations, including Indianapolis, Logansport, and Noblesville.
AON, founded in 2018, is rapidly expanding across the United States and currently includes over 300 providers across 20 states. AON aims to enhance community oncology through a physician-led model that stresses innovative, value-based care. This structure supports the long-term success of oncology practices while emphasizing equitable access to quality care for all patients.
For more information about HOI and AON, visit their respective websites at hematologyoncologyin.com and AONcology.com.
MWN-AI** Analysis
As an analyst observing the healthcare sector's dynamic landscape, the recent integration of Dr. Amy Braden into Hematology Oncology of Indiana (HOI) provides an insightful lens into market positioning and strategic growth potential for both HOI and the American Oncology Network (AON). Given Dr. Braden’s extensive background, including over a decade in patient care, her addition is likely to bolster HOI’s service offerings, particularly in light of the growing demand for specialized oncology care.
Market trends indicate a rising focus on personalized medicine and community-based healthcare solutions. HOI's commitment to high-quality, patient-centered care aligns with these trends, positioning it well to capture market share in an increasingly competitive landscape. The practice's comprehensive treatment capabilities—including infusion services, clinical trials, and BiTE therapy—enhance its value proposition, appealing to both existing and new patients.
Moreover, AON’s model emphasizes value-based care, addressing cost efficiency and improved patient outcomes, which is increasingly important to healthcare payers and providers alike. The expansion of AON’s network to over 300 providers across 20 states, combined with HOI’s local expertise, affords both organizations the opportunity to consolidate resources and leverage economies of scale. This can lead to improved operational efficiencies, marketing synergies, and a stronger competitive stance against larger oncology centers and health systems.
Investors and stakeholders should monitor HOI and AON’s performance, particularly in how effectively they can integrate Dr. Braden’s expertise and enhance their ongoing initiatives aimed at health equity. The combined strength of community engagement and specialized care is poised to offer a compelling investment thesis as the oncology sector increasingly turns towards solutions that prioritize patient-centered care and accessibility. In conclusion, HOI's strategic hiring, backed by AON’s expansive support network, signals a robust growth trajectory worth tracking in the evolving oncology market.
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
INDIANAPOLIS, Feb. 03, 2026 (GLOBE NEWSWIRE) -- Hematology Oncology of Indiana (HOI) and American Oncology Network (AON), one of the nation’s fastest-growing networks of community-based oncology practices, is pleased to announce that Amy Braden, DO, has joined the practice’s physician team and is now accepting new patients.
Dr. Braden is a Board-certified medical oncologist and hematologist with more than 10 years of experience in patient care. She earned her Doctorate of Osteopathic Medicine degree from Nova Southeastern University in Fort Lauderdale, Florida. She then completed her internal medicine residency at the Medical College of Wisconsin in Milwaukee, followed by a hematology and oncology fellowship at the University of Wisconsin in Madison.
“I am thrilled to join Hematology Oncology of Indiana,” said Dr. Braden. “The practice has a long-standing reputation for delivering the high-quality, patient-centered community cancer care that I value, and I look forward to collaborating with the physician team to continue delivering exceptional care to patients in Indiana.”
“We are pleased to welcome Dr. Braden to Hematology Oncology of Indiana,” said Brian P. Mulherin, MD, a Board-certified hematologist and oncologist at the practice. “Her impressive background and dedication to personalized care make her an excellent addition to our team. I’m confident our patients and physicians will benefit from her extensive knowledge and expertise.”
HOI provides high-quality community-based cancer care at six locations, including two practices in metropolitan Indianapolis, and additional locations in Logansport, Lebanon, Noblesville, and Fishers, Indiana. The practice offers a full range of exceptional cancer services, including specialty infusion services, pathology, pharmacy, clinical trials and BiTE therapy, providing treatment based on research and focused on the whole person.
“On behalf of AON, I’m excited to welcome Dr. Braden to Hematology Oncology of Indiana and to our national network,” said Stephen “Fred” Divers, MD, AON’s chief medical officer. “Her clinical expertise and commitment to delivering exceptional, patient-centered community-based cancer care will strengthen the care we offer in Indiana and across the network.”
Dr. Braden is now seeing patients at Hematology Oncology of Indiana’s Indianapolis, Logansport, and Noblesville locations.
For more information about American Oncology Network, visit www.AONcology.com. For more information about Hematology Oncology of Indiana, visit www.hematologyoncologyin.com.
About American Oncology Network
American Oncology Network (AON) is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success and viability of community oncology and other specialties. Founded in 2018, AON’s rapidly expanding network represents more than 300 providers practicing across 20 states. AON pioneers innovative healthcare solutions through its physician-led model, fostering value-based care that improves patient outcomes while reducing costs and expanding access to quality care. AON equips its network physicians with the tools they need to thrive independently while providing comprehensive support, integrated revenue-diversifying ancillary services, and practice management expertise, enabling physicians to focus on what matters most – providing the highest standard of care for every patient. AON is committed to promoting health equity by addressing disparities in cancer care and ensuring that all patients have access to the care they need to achieve optimal health outcomes. With a focus on innovation and collaboration, AON is shaping the future of community oncology. For more information, please visit AONcology.com or follow us on LinkedIn, Facebook, X (formerly Twitter) and YouTube.
About Hematology Oncology of Indiana
Hematology Oncology of Indiana is a community-based medical oncology and hematology practice providing treatment for patients diagnosed with all types of cancer and blood disorders. Through compassionate care that centers around the patient, Hematology Oncology of Indiana strives to provide the best possible experience to patients and their families throughout the healthcare journey. Learn more at hematologyoncology.com.
A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/00b9051a-b8b0-415b-98d2-c0ea49875a8e
Contact:Karen Riley SawyerAmerican Oncology NetworkKaren.Sawyer@AONcology.com
FAQ**
How will the addition of Dr. Amy Braden to Hematology Oncology of Indiana enhance the patient experience in the context of the American Oncology Network Inc. AONC’s commitment to providing patient-centered care?
What specific innovations in community oncology is the American Oncology Network Inc. AONC planning to implement with Dr. Braden's expertise to improve cancer care delivery in Indiana?
Can you elaborate on how the partnerships within the American Oncology Network Inc. AONC will facilitate access to clinical trials and specialized treatments at Hematology Oncology of Indiana?
In what ways does Hematology Oncology of Indiana, as part of the American Oncology Network Inc. AONC, address health disparities in cancer care within the communities it serves?
**MWN-AI FAQ is based on asking OpenAI questions about American Oncology Network Inc. (OTC: AONC).
NASDAQ: AONC
AONC Trading
0.0% G/L:
$11.12 Last:
350 Volume:
$11.12 Open:
